Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Cancer Detection Test Fails in Major Study

The New York Times – Business:

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in later stages of the disease.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Cancer, Clinical Trials, DNA (Deoxyribonucleic Acid), Food and Drug Administration, Grail Inc, Health Insurance and Managed Care, Regulation and Deregulation of Industry, Research, Tests (Medical)
←Opendoor rises as JPMorgan boosts earnings estimates following Q4 results
Nvidia nears $30 billion investment in OpenAI’s funding round, the FT reports→

More posts

  • Gen Z can’t afford the culture war

  • Confessions of a Pants Girl: How I Finally Came to Love the Skirt

  • Goodfellas Unveils First Images For Toho’s Sci-Fi Thriller ‘Leviathan’ & Fall Lineup – AFM

  • Fake alerts warn of nuclear danger as Ukraine and Russia report emergency app hacks

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube